NO992944D0 - Active ingredient for the delivery of apomorphine in the oral cavity - Google Patents
Active ingredient for the delivery of apomorphine in the oral cavityInfo
- Publication number
- NO992944D0 NO992944D0 NO992944A NO992944A NO992944D0 NO 992944 D0 NO992944 D0 NO 992944D0 NO 992944 A NO992944 A NO 992944A NO 992944 A NO992944 A NO 992944A NO 992944 D0 NO992944 D0 NO 992944D0
- Authority
- NO
- Norway
- Prior art keywords
- apomorphine
- delivery
- active ingredient
- oral cavity
- oral
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19652268A DE19652268C2 (en) | 1996-12-16 | 1996-12-16 | Medicinal preparation for the release of apomorphine in the oral cavity |
PCT/EP1997/006529 WO1998026763A1 (en) | 1996-12-16 | 1997-11-21 | Active substance carrier for releasing apomorphine into the buccal cavity |
Publications (2)
Publication Number | Publication Date |
---|---|
NO992944D0 true NO992944D0 (en) | 1999-06-16 |
NO992944L NO992944L (en) | 1999-06-16 |
Family
ID=7814859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO992944A NO992944L (en) | 1996-12-16 | 1999-06-16 | Active ingredient for the delivery of apomorphine in the oral cavity |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0959875A1 (en) |
JP (1) | JP2001506612A (en) |
KR (1) | KR20000057627A (en) |
AU (1) | AU746373B2 (en) |
CA (1) | CA2274893A1 (en) |
DE (1) | DE19652268C2 (en) |
NO (1) | NO992944L (en) |
WO (1) | WO1998026763A1 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9803240D0 (en) | 1998-09-24 | 1998-09-24 | Diabact Ab | A pharmaceutical composition having a rapid action |
US6596298B2 (en) | 1998-09-25 | 2003-07-22 | Warner-Lambert Company | Fast dissolving orally comsumable films |
US6291471B1 (en) | 1998-12-17 | 2001-09-18 | Abb Holdings, Inc. | Use of apomorphine for the treatment of organic erectile dysfunction in males |
JP2002533693A (en) | 1998-12-23 | 2002-10-08 | マウント シナイ スクール オブ メディシン オブ ニューヨーク ユニバーシティー | Inhibitors of bitter response |
US7314716B2 (en) | 1999-11-19 | 2008-01-01 | Mount Sinai School Of Medicine | Gustducin γ subunit materials and methods |
US7067116B1 (en) | 2000-03-23 | 2006-06-27 | Warner-Lambert Company Llc | Fast dissolving orally consumable solid film containing a taste masking agent and pharmaceutically active agent at weight ratio of 1:3 to 3:1 |
USRE44145E1 (en) | 2000-07-07 | 2013-04-09 | A.V. Topchiev Institute Of Petrochemical Synthesis | Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties |
US8840918B2 (en) | 2001-05-01 | 2014-09-23 | A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences | Hydrogel compositions for tooth whitening |
RU2276998C2 (en) | 2001-05-01 | 2006-05-27 | Институт Нефтехимического Синтеза Имени А.В. Топчиева Российской Академии Наук | Hydrogel compositions |
US20050215727A1 (en) | 2001-05-01 | 2005-09-29 | Corium | Water-absorbent adhesive compositions and associated methods of manufacture and use |
US8541021B2 (en) | 2001-05-01 | 2013-09-24 | A.V. Topchiev Institute Of Petrochemical Synthesis | Hydrogel compositions demonstrating phase separation on contact with aqueous media |
US8206738B2 (en) | 2001-05-01 | 2012-06-26 | Corium International, Inc. | Hydrogel compositions with an erodible backing member |
DE10252726B4 (en) * | 2002-11-13 | 2008-05-08 | Lts Lohmann Therapie-Systeme Ag | Multilayer transmucosal therapeutic system |
AU2003277788A1 (en) * | 2002-11-14 | 2004-06-03 | Givaudan Sa | Edible film containing food acid |
KR100945741B1 (en) * | 2003-01-16 | 2010-03-05 | 부광약품 주식회사 | Oral spray preparation of apomorphine hydrochloride |
US8658201B2 (en) * | 2004-01-30 | 2014-02-25 | Corium International, Inc. | Rapidly dissolving film for delivery of an active agent |
US20050281757A1 (en) * | 2004-06-17 | 2005-12-22 | Sayed Ibrahim | Oral care film |
EP2387394B1 (en) | 2009-01-14 | 2018-05-02 | Corium International, Inc. | Transdermal administration of tamsulosin |
EP2952191B1 (en) * | 2009-06-12 | 2018-08-22 | Sunovion Pharmaceuticals Inc. | Sublingual apomorphine |
CA3115378A1 (en) | 2010-12-16 | 2012-06-21 | Sunovion Pharmaceuticals Inc. | Sublingual films comprising apomorphine and an organic base |
US10806703B2 (en) | 2012-01-20 | 2020-10-20 | Lts Lohmann Therapie-System Ag | Transmucosal administration system for a pharmaceutical drug |
MX2016006087A (en) * | 2013-11-11 | 2016-08-12 | Impax Laboratories Inc | Rapidly disintegrating formulations and methods of use. |
WO2016172095A1 (en) | 2015-04-21 | 2016-10-27 | Cynapsus Therapeutics, Inc. | Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3972995A (en) * | 1975-04-14 | 1976-08-03 | American Home Products Corporation | Dosage form |
DE2746414A1 (en) * | 1977-10-15 | 1979-04-26 | Gerlach Eduard Chem Fab | Foil-like tape for dispensing measured amts. of substance - consisting of the substance, binding agent and adjuvants, tape length being proportional to weight of substance |
ATE312609T1 (en) * | 1994-04-22 | 2005-12-15 | Pentech Pharmaceuticals Inc | SUBLINGUAL COMPOSITION CONTAINING APOMORPHINE FOR THE DIAGNOSTICS OF FUNCTIONAL IMPOTENCY |
FR2732896B1 (en) * | 1995-04-11 | 1997-06-13 | Prographarm Lab | TRANSDERMAL PHARMACEUTICAL FORM FOR PERCUTANEOUS ADMINISTRATION OF APOMORPHINE |
-
1996
- 1996-12-16 DE DE19652268A patent/DE19652268C2/en not_active Expired - Fee Related
-
1997
- 1997-11-21 WO PCT/EP1997/006529 patent/WO1998026763A1/en not_active Application Discontinuation
- 1997-11-21 CA CA002274893A patent/CA2274893A1/en not_active Abandoned
- 1997-11-21 JP JP52593498A patent/JP2001506612A/en active Pending
- 1997-11-21 EP EP97952795A patent/EP0959875A1/en not_active Withdrawn
- 1997-11-21 AU AU56547/98A patent/AU746373B2/en not_active Ceased
- 1997-11-21 KR KR1019990705422A patent/KR20000057627A/en not_active Application Discontinuation
-
1999
- 1999-06-16 NO NO992944A patent/NO992944L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO992944L (en) | 1999-06-16 |
KR20000057627A (en) | 2000-09-25 |
WO1998026763A1 (en) | 1998-06-25 |
AU5654798A (en) | 1998-07-15 |
JP2001506612A (en) | 2001-05-22 |
DE19652268A1 (en) | 1998-06-18 |
CA2274893A1 (en) | 1998-06-25 |
AU746373B2 (en) | 2002-04-18 |
EP0959875A1 (en) | 1999-12-01 |
DE19652268C2 (en) | 2000-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO992944D0 (en) | Active ingredient for the delivery of apomorphine in the oral cavity | |
FI973828A0 (en) | Compounds and compositions for administering the active ingredients | |
ID17553A (en) | FORM OF ORAL DOSAGE SOLIDITY | |
DK1093815T3 (en) | Oral 2-methyl-thieno-benzodiazepine formulation | |
HUP9601566A3 (en) | Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component | |
TR199501137A2 (en) | Therapeutically active ingredients | |
EE200000395A (en) | Oral pharmaceutical pulsatile dosage form | |
DK0797991T3 (en) | Delayed-release drug formulation | |
DE69530325D1 (en) | AEROSOL DRUG FORMULATIONS | |
MA26456A1 (en) | PHARMACEUTICAL FORMULATIONS FOR THE EXTENDED DELIVERY OF MEDICAMENT. | |
KR970006279A (en) | 6-Dimethylaminomethyl-1-phenyl-cyclohexane compound as active pharmaceutical ingredient | |
ID22565A (en) | USE OF NANODISPERION IN FINAL DRUG FORMULATION | |
IS5248A (en) | Pharmaceutical formulations containing voriconazole | |
MA26507A1 (en) | AEROSOL PHARMACEUTICAL COMPOSITIONS | |
NO954486D0 (en) | Pharmaceutical formulation basis | |
HUP0102864A2 (en) | Anti-inflammatory dental care agent | |
DE69822172D1 (en) | LEVOSIMENT-CONTAINING ORAL MEDICINAL COMPOSITIONS | |
NO992564L (en) | The use of mixtures of active ingredients for the preparation of hypocholesterolemic agents | |
NO20001717D0 (en) | Serotonin-containing formulation for oral administration and use of the same | |
IT1291340B1 (en) | PHARMACEUTICAL FORMULATIONS CONTAINING COLOSTRUM AND USE OF COLOSTRUM FOR THE TREATMENT OF ORAL CAVITY DISEASES | |
IS5062A (en) | Medicinal preparations containing N-sulfonylindoline derivatives | |
ITMI941169A0 (en) | PHARMACEUTICAL FORMULATIONS | |
HU9802886D0 (en) | Substituted heterocyclic benzocycloalkenes and their use as analgetic active ingredients | |
NO975680D0 (en) | Oral pharmaceutical preparation of piperidinoalkanol compounds in solution form | |
HUP0104238A3 (en) | Benzoxazole derivatives and drugs containing the same as the active ingredient and their use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |